Utility of serum interleukin-6 for diagnosis of invasive bacterial disease in children

This publication has 15 references indexed in Scilit:

• A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis
  JAMA, 1991
• Letʼs agree on terminology
  Critical Care Medicine, 1991
• Strategies for diagnosis and treatment of children at risk for occult bacteremia: Clinical effectiveness and cost-effectiveness
  The Journal of Pediatrics, 1991
• The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
  The Journal of Experimental Medicine, 1989
• Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
  Journal of Clinical Investigation, 1988
• B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.
  The Journal of Experimental Medicine, 1988
• Monocyte-Derived Human B-Cell Growth Factor Identified as Interferon-β ₂ (BSF-2, IL-6)
  Science, 1988
• Shock and Tissue Injury Induced by Recombinant Human Cachectin
  Science, 1986
• Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation
  Cell, 1986
• Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor
  European Journal of Biochemistry, 1985